Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Deepa Manwani, Arthur Burnett, Jincy Paulose, Glorian P. Yen, Tanya Burton, Amy Anderson, Sara Wang, Soyon Lee, Santosh L. Saraf

Blood (2021) 138 (Supplement 1): 4055.

https://doi.org/10.1182/blood-2021-147956

Published: 2021

Journal Articles

Real-World Analysis of Ruxolitinib Treatment Patterns and Outcomes Among Patients with Myelofibrosis

Tanya Burton, Kejal Parikh, Manish Patel, Kevin Sundquist, Lincy S. Lal, Ronda Copher, Aaron T. Gerds, MD MS

Blood (2019) 134 (Supplement_1): 4750.

https://doi.org/10.1182/blood-2019-124651

Published: 2019

Journal Articles

Blood and Resource Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA) in the Pre- and Post-National Coverage Determination (NCD) Timeframes: Results From An Electronic Medical Record Study.

Tanya Burton, PhD, Luke Boulanger, MA, MBA, Kay Larholt, ScD, Chris L. Pashos, PhD, R. Scott McKenzie, MD, Mekré Senbetta, PharmD, Janice Lopez, PharmD, Devi Sundaresan, MS, Peggy Preusse, RN, Christopher Seidler, MD

Blood (2009) 114 (22): 2472.

https://doi.org/10.1182/blood.V114.22.2472.2472

Published: 2009

Journal Articles

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Tanya Burton, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. Scott Mckenzie, MD

Blood (2008) 112 (11): 1301.

https://doi.org/10.1182/blood.V112.11.1301.1301

Published: 2008

Journal Articles

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Tanya Burton, PhD, David Hoaglin, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. scott McKenzie, MD

Blood (2008) 112 (11): 1304.

https://doi.org/10.1182/blood.V112.11.1304.1304

Published: 2008

Journal Articles

Hemoglobin Levels Prior to Blood Transfusions in Oncology Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the DOSE Registry.

Kay M. Larholt, ScD, Tanya Burton, PhD, Chris L. Pashos, PhD, Brahim K. Bookhart, MBA, MPH, Catherine Tak Piech, MBA, Scott R. McKenzie, MD

Blood (2007) 110 (11): 4019.

https://doi.org/10.1182/blood.V110.11.4019.4019

Published: 2007

NARROW

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Real-World Analysis of Ruxolitinib Treatment Patterns and Outcomes Among Patients with Myelofibrosis

Blood and Resource Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA) in the Pre- and Post-National Coverage Determination (NCD) Timeframes: Results From An Electronic Medical Record Study.

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Hemoglobin Levels Prior to Blood Transfusions in Oncology Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the DOSE Registry.

Email alerts

ASH Publications

American Society of Hematology

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Real-World Analysis of Ruxolitinib Treatment Patterns and Outcomes Among Patients with Myelofibrosis

Blood and Resource Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA) in the Pre- and Post-National Coverage Determination (NCD) Timeframes: Results From An Electronic Medical Record Study.

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Hemoglobin Levels Prior to Blood Transfusions in Oncology Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents (ESAs): Observational Data from the DOSE Registry.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only